Du är här


Nuevolution: Redeye: Nuevolution - Strengthening the foundation & Cytokine X unveiled

The second quarter showed stable operational progress for Nuevolution
and the company also completed a directed share issue as well as an
up-listing to the Nasdaq Stockholm main market, improving the
company's foundation.

Read more and download the research update: http://bit.ly/2LYGboP

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment
Banking. https://www.redeye.se/about/


Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.